文献速递头颈部肿瘤放疗放疗物理与技术

头颈部鳞状细胞癌患者下颌骨放射性骨坏死危险因素

Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.
PubMed 文献 · Radiat Oncol · 2021-01-05

该回顾性研究纳入2008-2018年接受根治性或术后放疗的616例头颈部鳞状细胞癌患者,评估与下颌骨放射性骨坏死(ORNJ)相关的因素,重点分析下颌骨剂量体积直方图参数。多因素分析显示V60>14%和原发肿瘤部位(口咽或口腔癌)是ORNJ的独立危险因素。

要点

  • V60>14%是ORNJ独立危险因素(p=0.0065)。
  • 口咽或口腔癌患者ORNJ风险显著高于其他部位(p<0.0001)。
  • V60≤14%与>14%患者3年累积ORNJ发生率分别为2.5%和8.6%。

核心结论

  • V60>14%和口咽或口腔癌是头颈部鳞状细胞癌根治性放疗后ORNJ的独立危险因素。

研究设计与样本

  • 回顾性队列研究,纳入2008-2018年接受根治性或术后放疗的616例头颈部鳞状细胞癌患者。

主要发现

  • ORNJ患者V30-V70值显著高于无ORNJ患者。
  • 单因素分析中,原发肿瘤部位、放疗前下颌骨手术、放疗后拔牙和V60>14%为重要因素。
  • 多因素分析中V60>14%(p=0.0065)和原发肿瘤部位(p=0.0059)保持显著。
  • V60≤14%与>14%患者3年累积ORNJ发生率分别为2.5%和8.6%(p<0.0001);口咽或口腔癌与其他癌症分别为9.3%和1.4%(p<0.0001)。

关键数值与推荐

  • V60>14%定义为下颌骨接受≥60 Gy的相对体积超过14%。
  • 口咽或口腔癌原发部位为ORNJ独立危险因素。

临床怎么用

  • 在头颈部鳞状细胞癌根治性放疗计划中,应关注下颌骨V60,尽量将其控制在14%以下以降低ORNJ风险。
  • 对口咽或口腔癌患者应加强ORNJ监测与预防。

局限性

  • 回顾性研究设计。
  • 单中心数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate factors associated with osteoradionecrosis of the jaw (ORNJ) in patients with head and neck squamous cell carcinoma (HNSCC), focusing on jaw-related dose-volume histogram (DVH) parameters. METHODS: We retrospectively reviewed the medical records of 616 patients with HNSCC treated with curative-intent or postoperative radiation therapy (RT) during 2008-2018. Patient-related (age, sex, history of smoking or alcohol use, diabetes mellitus, performance status, pre-RT dental evaluation, pre- or post-RT tooth extraction), tumor-related (primary tumor site, T-stage, nodal status), and treatment-related (pre-RT surgery, pre-RT mandible surgery, induction or concurrent chemotherapy, RT technique) variables and DVH parameters (relative volumes of the jaw exposed to doses of 10 Gy-70 Gy [V10-70]) were investigated and compared between patients with and without ORNJ. The Mann-Whitney U test was used to compare RT dose parameters. Univariate and multivariate Cox regression analyses were used to assess factors associated with ORNJ development. Kaplan-Meier analyses were performed for cumulative ORNJ incidence estimation. RESULTS: Forty-six patients (7.5%) developed ORNJ. The median follow-up duration was 40 (range 3-145) months. The median time to ORNJ development was 27 (range 2-127) months. DVH analysis revealed that V30-V70 values were significantly higher in patients with than in those without ORNJ. In univariate analyses, primary tumor site, pre-RT mandible surgery, post-RT tooth extraction, and V60 > 14% were identified as important factors. In multivariate analyses, V60 > 14% (p = 0.0065) and primary tumor site (p = 0.0059) remained significant. The 3-year cumulative ORNJ incidence rates were 2.5% and 8.6% in patients with V60 ≤ 14% and > 14%, respectively (p < 0.0001), and 9.3% and 1.4% in patients with oropharyngeal or oral cancer and other cancers, respectively (p < 0.0001). CONCLUSIONS: V60 > 14% and oropharyngeal or oral cancer were found to be independent risk factors for ORNJ. These findings might be useful to minimize ORNJ incidence in HNSCC treated with curative RT.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kubota H, Miyawaki D, Mukumoto N, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2021. PMID: 33402192. doi:10.1186/s13014-020-01701-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。